nodes	percent_of_prediction	percent_of_DWPC	metapath
Carbidopa—Hypertension—Prednisolone—ankylosing spondylitis	0.00286	0.00287	CcSEcCtD
Carbidopa—Ill-defined disorder—Triamcinolone—ankylosing spondylitis	0.00283	0.00284	CcSEcCtD
Carbidopa—Ill-defined disorder—Methylprednisolone—ankylosing spondylitis	0.00282	0.00283	CcSEcCtD
Carbidopa—Alopecia—Betamethasone—ankylosing spondylitis	0.00281	0.00282	CcSEcCtD
Carbidopa—Alopecia—Dexamethasone—ankylosing spondylitis	0.00281	0.00282	CcSEcCtD
Carbidopa—Discomfort—Prednisolone—ankylosing spondylitis	0.00279	0.0028	CcSEcCtD
Carbidopa—Angioedema—Triamcinolone—ankylosing spondylitis	0.00279	0.00279	CcSEcCtD
Carbidopa—Haemoglobin—Prednisone—ankylosing spondylitis	0.00278	0.00279	CcSEcCtD
Carbidopa—Angioedema—Methylprednisolone—ankylosing spondylitis	0.00278	0.00279	CcSEcCtD
Carbidopa—Haemorrhage—Prednisone—ankylosing spondylitis	0.00277	0.00277	CcSEcCtD
Carbidopa—Hallucination—Prednisone—ankylosing spondylitis	0.00275	0.00276	CcSEcCtD
Carbidopa—Malaise—Triamcinolone—ankylosing spondylitis	0.00275	0.00276	CcSEcCtD
Carbidopa—Malaise—Methylprednisolone—ankylosing spondylitis	0.00274	0.00275	CcSEcCtD
Carbidopa—Syncope—Triamcinolone—ankylosing spondylitis	0.00273	0.00274	CcSEcCtD
Carbidopa—Epinephrine—TNF—ankylosing spondylitis	0.00273	1	CrCbGaD
Carbidopa—Syncope—Methylprednisolone—ankylosing spondylitis	0.00273	0.00273	CcSEcCtD
Carbidopa—Oedema—Prednisolone—ankylosing spondylitis	0.00271	0.00271	CcSEcCtD
Carbidopa—Upper respiratory tract infection—Methotrexate—ankylosing spondylitis	0.00268	0.00269	CcSEcCtD
Carbidopa—Loss of consciousness—Triamcinolone—ankylosing spondylitis	0.00268	0.00269	CcSEcCtD
Carbidopa—Loss of consciousness—Methylprednisolone—ankylosing spondylitis	0.00267	0.00268	CcSEcCtD
Carbidopa—Shock—Prednisolone—ankylosing spondylitis	0.00266	0.00267	CcSEcCtD
Carbidopa—Cough—Triamcinolone—ankylosing spondylitis	0.00266	0.00267	CcSEcCtD
Carbidopa—Convulsion—Triamcinolone—ankylosing spondylitis	0.00264	0.00265	CcSEcCtD
Carbidopa—Convulsion—Methylprednisolone—ankylosing spondylitis	0.00263	0.00264	CcSEcCtD
Carbidopa—Hypertension—Triamcinolone—ankylosing spondylitis	0.00263	0.00264	CcSEcCtD
Carbidopa—Hypertension—Methylprednisolone—ankylosing spondylitis	0.00263	0.00263	CcSEcCtD
Carbidopa—Hyperhidrosis—Prednisolone—ankylosing spondylitis	0.00262	0.00262	CcSEcCtD
Carbidopa—Anxiety—Methylprednisolone—ankylosing spondylitis	0.00258	0.00259	CcSEcCtD
Carbidopa—Depression—Methotrexate—ankylosing spondylitis	0.00257	0.00258	CcSEcCtD
Carbidopa—Flushing—Prednisone—ankylosing spondylitis	0.00257	0.00257	CcSEcCtD
Carbidopa—Ill-defined disorder—Dexamethasone—ankylosing spondylitis	0.00257	0.00257	CcSEcCtD
Carbidopa—Ill-defined disorder—Betamethasone—ankylosing spondylitis	0.00257	0.00257	CcSEcCtD
Carbidopa—Discomfort—Triamcinolone—ankylosing spondylitis	0.00256	0.00257	CcSEcCtD
Carbidopa—Discomfort—Methylprednisolone—ankylosing spondylitis	0.00256	0.00257	CcSEcCtD
Carbidopa—Dry mouth—Triamcinolone—ankylosing spondylitis	0.00254	0.00254	CcSEcCtD
Carbidopa—Angioedema—Betamethasone—ankylosing spondylitis	0.00253	0.00253	CcSEcCtD
Carbidopa—Angioedema—Dexamethasone—ankylosing spondylitis	0.00253	0.00253	CcSEcCtD
Carbidopa—Confusional state—Methylprednisolone—ankylosing spondylitis	0.0025	0.00251	CcSEcCtD
Carbidopa—Malaise—Dexamethasone—ankylosing spondylitis	0.00249	0.0025	CcSEcCtD
Carbidopa—Malaise—Betamethasone—ankylosing spondylitis	0.00249	0.0025	CcSEcCtD
Carbidopa—Oedema—Triamcinolone—ankylosing spondylitis	0.00249	0.00249	CcSEcCtD
Carbidopa—Syncope—Betamethasone—ankylosing spondylitis	0.00248	0.00249	CcSEcCtD
Carbidopa—Syncope—Dexamethasone—ankylosing spondylitis	0.00248	0.00249	CcSEcCtD
Carbidopa—Infection—Triamcinolone—ankylosing spondylitis	0.00247	0.00248	CcSEcCtD
Carbidopa—Infection—Methylprednisolone—ankylosing spondylitis	0.00247	0.00247	CcSEcCtD
Carbidopa—Shock—Triamcinolone—ankylosing spondylitis	0.00245	0.00245	CcSEcCtD
Carbidopa—Insomnia—Prednisolone—ankylosing spondylitis	0.00245	0.00245	CcSEcCtD
Carbidopa—Alopecia—Prednisone—ankylosing spondylitis	0.00244	0.00245	CcSEcCtD
Carbidopa—Shock—Methylprednisolone—ankylosing spondylitis	0.00244	0.00245	CcSEcCtD
Carbidopa—Loss of consciousness—Betamethasone—ankylosing spondylitis	0.00243	0.00244	CcSEcCtD
Carbidopa—Loss of consciousness—Dexamethasone—ankylosing spondylitis	0.00243	0.00244	CcSEcCtD
Carbidopa—Paraesthesia—Prednisolone—ankylosing spondylitis	0.00243	0.00244	CcSEcCtD
Carbidopa—Mental disorder—Prednisone—ankylosing spondylitis	0.00242	0.00243	CcSEcCtD
Carbidopa—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	0.0024	0.00241	CcSEcCtD
Carbidopa—Agranulocytosis—Methotrexate—ankylosing spondylitis	0.0024	0.00241	CcSEcCtD
Carbidopa—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	0.0024	0.00241	CcSEcCtD
Carbidopa—Convulsion—Dexamethasone—ankylosing spondylitis	0.0024	0.0024	CcSEcCtD
Carbidopa—Convulsion—Betamethasone—ankylosing spondylitis	0.0024	0.0024	CcSEcCtD
Carbidopa—Hypertension—Dexamethasone—ankylosing spondylitis	0.00239	0.00239	CcSEcCtD
Carbidopa—Hypertension—Betamethasone—ankylosing spondylitis	0.00239	0.00239	CcSEcCtD
Carbidopa—Anxiety—Dexamethasone—ankylosing spondylitis	0.00235	0.00235	CcSEcCtD
Carbidopa—Anxiety—Betamethasone—ankylosing spondylitis	0.00235	0.00235	CcSEcCtD
Carbidopa—Discomfort—Betamethasone—ankylosing spondylitis	0.00233	0.00233	CcSEcCtD
Carbidopa—Discomfort—Dexamethasone—ankylosing spondylitis	0.00233	0.00233	CcSEcCtD
Carbidopa—Haemoglobin—Methotrexate—ankylosing spondylitis	0.00232	0.00233	CcSEcCtD
Carbidopa—Hypotension—Methylprednisolone—ankylosing spondylitis	0.00232	0.00233	CcSEcCtD
Carbidopa—Pain—Prednisolone—ankylosing spondylitis	0.00231	0.00232	CcSEcCtD
Carbidopa—Haemorrhage—Methotrexate—ankylosing spondylitis	0.00231	0.00232	CcSEcCtD
Carbidopa—Urinary tract disorder—Methotrexate—ankylosing spondylitis	0.00228	0.00229	CcSEcCtD
Carbidopa—Vision blurred—Prednisone—ankylosing spondylitis	0.00227	0.00228	CcSEcCtD
Carbidopa—Urethral disorder—Methotrexate—ankylosing spondylitis	0.00227	0.00227	CcSEcCtD
Carbidopa—Oedema—Dexamethasone—ankylosing spondylitis	0.00226	0.00226	CcSEcCtD
Carbidopa—Oedema—Betamethasone—ankylosing spondylitis	0.00226	0.00226	CcSEcCtD
Carbidopa—Insomnia—Triamcinolone—ankylosing spondylitis	0.00225	0.00226	CcSEcCtD
Carbidopa—Insomnia—Methylprednisolone—ankylosing spondylitis	0.00224	0.00225	CcSEcCtD
Carbidopa—Infection—Dexamethasone—ankylosing spondylitis	0.00224	0.00225	CcSEcCtD
Carbidopa—Infection—Betamethasone—ankylosing spondylitis	0.00224	0.00225	CcSEcCtD
Carbidopa—Ill-defined disorder—Prednisone—ankylosing spondylitis	0.00223	0.00224	CcSEcCtD
Carbidopa—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.00223	0.00224	CcSEcCtD
Carbidopa—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.00223	0.00224	CcSEcCtD
Carbidopa—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.00223	0.00223	CcSEcCtD
Carbidopa—Anaemia—Prednisone—ankylosing spondylitis	0.00223	0.00223	CcSEcCtD
Carbidopa—Shock—Dexamethasone—ankylosing spondylitis	0.00222	0.00223	CcSEcCtD
Carbidopa—Shock—Betamethasone—ankylosing spondylitis	0.00222	0.00223	CcSEcCtD
Carbidopa—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.00222	0.00222	CcSEcCtD
Carbidopa—Agitation—Prednisone—ankylosing spondylitis	0.00221	0.00222	CcSEcCtD
Carbidopa—Thrombocytopenia—Betamethasone—ankylosing spondylitis	0.00221	0.00222	CcSEcCtD
Carbidopa—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	0.00221	0.00222	CcSEcCtD
Carbidopa—Angioedema—Prednisone—ankylosing spondylitis	0.0022	0.00221	CcSEcCtD
Carbidopa—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.00219	0.0022	CcSEcCtD
Carbidopa—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.00218	0.00219	CcSEcCtD
Carbidopa—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	0.00218	0.00219	CcSEcCtD
Carbidopa—Hyperhidrosis—Betamethasone—ankylosing spondylitis	0.00218	0.00219	CcSEcCtD
Carbidopa—Malaise—Prednisone—ankylosing spondylitis	0.00217	0.00218	CcSEcCtD
Carbidopa—Syncope—Prednisone—ankylosing spondylitis	0.00216	0.00217	CcSEcCtD
Carbidopa—Anorexia—Betamethasone—ankylosing spondylitis	0.00215	0.00216	CcSEcCtD
Carbidopa—Anorexia—Dexamethasone—ankylosing spondylitis	0.00215	0.00216	CcSEcCtD
Carbidopa—Urticaria—Prednisolone—ankylosing spondylitis	0.00215	0.00215	CcSEcCtD
Carbidopa—Fatigue—Triamcinolone—ankylosing spondylitis	0.00214	0.00215	CcSEcCtD
Carbidopa—Fatigue—Methylprednisolone—ankylosing spondylitis	0.00214	0.00215	CcSEcCtD
Carbidopa—Pain—Triamcinolone—ankylosing spondylitis	0.00213	0.00213	CcSEcCtD
Carbidopa—Loss of consciousness—Prednisone—ankylosing spondylitis	0.00212	0.00212	CcSEcCtD
Carbidopa—Hypotension—Betamethasone—ankylosing spondylitis	0.00211	0.00211	CcSEcCtD
Carbidopa—Hypotension—Dexamethasone—ankylosing spondylitis	0.00211	0.00211	CcSEcCtD
Carbidopa—Convulsion—Prednisone—ankylosing spondylitis	0.00209	0.00209	CcSEcCtD
Carbidopa—Hypertension—Prednisone—ankylosing spondylitis	0.00208	0.00209	CcSEcCtD
Carbidopa—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.00205	0.00206	CcSEcCtD
Carbidopa—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.00205	0.00205	CcSEcCtD
Carbidopa—Anxiety—Prednisone—ankylosing spondylitis	0.00204	0.00205	CcSEcCtD
Carbidopa—Alopecia—Methotrexate—ankylosing spondylitis	0.00204	0.00205	CcSEcCtD
Carbidopa—Insomnia—Dexamethasone—ankylosing spondylitis	0.00204	0.00205	CcSEcCtD
Carbidopa—Insomnia—Betamethasone—ankylosing spondylitis	0.00204	0.00205	CcSEcCtD
Carbidopa—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.00203	0.00204	CcSEcCtD
Carbidopa—Paraesthesia—Betamethasone—ankylosing spondylitis	0.00203	0.00203	CcSEcCtD
Carbidopa—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.00203	0.00203	CcSEcCtD
Carbidopa—Discomfort—Prednisone—ankylosing spondylitis	0.00203	0.00203	CcSEcCtD
Carbidopa—Mental disorder—Methotrexate—ankylosing spondylitis	0.00203	0.00203	CcSEcCtD
Carbidopa—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.00199	0.002	CcSEcCtD
Carbidopa—Dyspepsia—Betamethasone—ankylosing spondylitis	0.00199	0.00199	CcSEcCtD
Carbidopa—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.00199	0.00199	CcSEcCtD
Carbidopa—Urticaria—Triamcinolone—ankylosing spondylitis	0.00198	0.00198	CcSEcCtD
Carbidopa—Urticaria—Methylprednisolone—ankylosing spondylitis	0.00197	0.00198	CcSEcCtD
Carbidopa—Dysgeusia—Methotrexate—ankylosing spondylitis	0.00197	0.00198	CcSEcCtD
Carbidopa—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.00197	0.00197	CcSEcCtD
Carbidopa—Oedema—Prednisone—ankylosing spondylitis	0.00197	0.00197	CcSEcCtD
Carbidopa—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.00196	0.00197	CcSEcCtD
Carbidopa—Decreased appetite—Betamethasone—ankylosing spondylitis	0.00196	0.00197	CcSEcCtD
Carbidopa—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.00196	0.00197	CcSEcCtD
Carbidopa—Infection—Prednisone—ankylosing spondylitis	0.00195	0.00196	CcSEcCtD
Carbidopa—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.00195	0.00195	CcSEcCtD
Carbidopa—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.00195	0.00195	CcSEcCtD
Carbidopa—Back pain—Methotrexate—ankylosing spondylitis	0.00195	0.00195	CcSEcCtD
Carbidopa—Fatigue—Betamethasone—ankylosing spondylitis	0.00195	0.00195	CcSEcCtD
Carbidopa—Fatigue—Dexamethasone—ankylosing spondylitis	0.00195	0.00195	CcSEcCtD
Carbidopa—Shock—Prednisone—ankylosing spondylitis	0.00193	0.00194	CcSEcCtD
Carbidopa—Pain—Dexamethasone—ankylosing spondylitis	0.00193	0.00194	CcSEcCtD
Carbidopa—Pain—Betamethasone—ankylosing spondylitis	0.00193	0.00194	CcSEcCtD
Carbidopa—Hyperhidrosis—Prednisone—ankylosing spondylitis	0.0019	0.00191	CcSEcCtD
Carbidopa—Vision blurred—Methotrexate—ankylosing spondylitis	0.0019	0.0019	CcSEcCtD
Carbidopa—Anorexia—Prednisone—ankylosing spondylitis	0.00187	0.00188	CcSEcCtD
Carbidopa—Ill-defined disorder—Methotrexate—ankylosing spondylitis	0.00187	0.00187	CcSEcCtD
Carbidopa—Anaemia—Methotrexate—ankylosing spondylitis	0.00186	0.00187	CcSEcCtD
Carbidopa—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.00186	0.00187	CcSEcCtD
Carbidopa—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.00186	0.00187	CcSEcCtD
Carbidopa—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.00185	0.00185	CcSEcCtD
Carbidopa—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.00185	0.00185	CcSEcCtD
Carbidopa—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.00183	0.00184	CcSEcCtD
Carbidopa—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.00183	0.00183	CcSEcCtD
Carbidopa—Malaise—Methotrexate—ankylosing spondylitis	0.00182	0.00182	CcSEcCtD
Carbidopa—Leukopenia—Methotrexate—ankylosing spondylitis	0.0018	0.00181	CcSEcCtD
Carbidopa—Urticaria—Betamethasone—ankylosing spondylitis	0.00179	0.0018	CcSEcCtD
Carbidopa—Urticaria—Dexamethasone—ankylosing spondylitis	0.00179	0.0018	CcSEcCtD
Carbidopa—Dizziness—Prednisolone—ankylosing spondylitis	0.00179	0.00179	CcSEcCtD
Carbidopa—Asthenia—Triamcinolone—ankylosing spondylitis	0.00178	0.00179	CcSEcCtD
Carbidopa—Body temperature increased—Betamethasone—ankylosing spondylitis	0.00178	0.00179	CcSEcCtD
Carbidopa—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.00178	0.00179	CcSEcCtD
Carbidopa—Abdominal pain—Betamethasone—ankylosing spondylitis	0.00178	0.00179	CcSEcCtD
Carbidopa—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.00178	0.00179	CcSEcCtD
Carbidopa—Asthenia—Methylprednisolone—ankylosing spondylitis	0.00178	0.00179	CcSEcCtD
Carbidopa—Insomnia—Prednisone—ankylosing spondylitis	0.00178	0.00178	CcSEcCtD
Carbidopa—Paraesthesia—Prednisone—ankylosing spondylitis	0.00177	0.00177	CcSEcCtD
Carbidopa—Pruritus—Triamcinolone—ankylosing spondylitis	0.00176	0.00176	CcSEcCtD
Carbidopa—Cough—Methotrexate—ankylosing spondylitis	0.00176	0.00176	CcSEcCtD
Carbidopa—Pruritus—Methylprednisolone—ankylosing spondylitis	0.00176	0.00176	CcSEcCtD
Carbidopa—Convulsion—Methotrexate—ankylosing spondylitis	0.00174	0.00175	CcSEcCtD
Carbidopa—Dyspepsia—Prednisone—ankylosing spondylitis	0.00173	0.00174	CcSEcCtD
Carbidopa—Chest pain—Methotrexate—ankylosing spondylitis	0.00171	0.00172	CcSEcCtD
Carbidopa—Decreased appetite—Prednisone—ankylosing spondylitis	0.00171	0.00171	CcSEcCtD
Carbidopa—Rash—Prednisolone—ankylosing spondylitis	0.00171	0.00171	CcSEcCtD
Carbidopa—Dermatitis—Prednisolone—ankylosing spondylitis	0.0017	0.00171	CcSEcCtD
Carbidopa—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.0017	0.0017	CcSEcCtD
Carbidopa—Fatigue—Prednisone—ankylosing spondylitis	0.00169	0.0017	CcSEcCtD
Carbidopa—Headache—Prednisolone—ankylosing spondylitis	0.00169	0.0017	CcSEcCtD
Carbidopa—Discomfort—Methotrexate—ankylosing spondylitis	0.00169	0.0017	CcSEcCtD
Carbidopa—Constipation—Prednisone—ankylosing spondylitis	0.00168	0.00169	CcSEcCtD
Carbidopa—Confusional state—Methotrexate—ankylosing spondylitis	0.00166	0.00166	CcSEcCtD
Carbidopa—Dizziness—Triamcinolone—ankylosing spondylitis	0.00164	0.00165	CcSEcCtD
Carbidopa—Dizziness—Methylprednisolone—ankylosing spondylitis	0.00164	0.00165	CcSEcCtD
Carbidopa—Infection—Methotrexate—ankylosing spondylitis	0.00163	0.00164	CcSEcCtD
Carbidopa—Feeling abnormal—Prednisone—ankylosing spondylitis	0.00162	0.00162	CcSEcCtD
Carbidopa—Asthenia—Dexamethasone—ankylosing spondylitis	0.00162	0.00162	CcSEcCtD
Carbidopa—Asthenia—Betamethasone—ankylosing spondylitis	0.00162	0.00162	CcSEcCtD
Carbidopa—Thrombocytopenia—Methotrexate—ankylosing spondylitis	0.00161	0.00161	CcSEcCtD
Carbidopa—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.00161	0.00161	CcSEcCtD
Carbidopa—Nausea—Prednisolone—ankylosing spondylitis	0.00161	0.00161	CcSEcCtD
Carbidopa—Pruritus—Betamethasone—ankylosing spondylitis	0.0016	0.0016	CcSEcCtD
Carbidopa—Pruritus—Dexamethasone—ankylosing spondylitis	0.0016	0.0016	CcSEcCtD
Carbidopa—Hyperhidrosis—Methotrexate—ankylosing spondylitis	0.00159	0.00159	CcSEcCtD
Carbidopa—Vomiting—Triamcinolone—ankylosing spondylitis	0.00158	0.00159	CcSEcCtD
Carbidopa—Vomiting—Methylprednisolone—ankylosing spondylitis	0.00158	0.00158	CcSEcCtD
Carbidopa—Rash—Triamcinolone—ankylosing spondylitis	0.00157	0.00157	CcSEcCtD
Carbidopa—Dermatitis—Triamcinolone—ankylosing spondylitis	0.00157	0.00157	CcSEcCtD
Carbidopa—Anorexia—Methotrexate—ankylosing spondylitis	0.00157	0.00157	CcSEcCtD
Carbidopa—Rash—Methylprednisolone—ankylosing spondylitis	0.00156	0.00157	CcSEcCtD
Carbidopa—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.00156	0.00157	CcSEcCtD
Carbidopa—Urticaria—Prednisone—ankylosing spondylitis	0.00156	0.00157	CcSEcCtD
Carbidopa—Headache—Triamcinolone—ankylosing spondylitis	0.00156	0.00156	CcSEcCtD
Carbidopa—Headache—Methylprednisolone—ankylosing spondylitis	0.00155	0.00156	CcSEcCtD
Carbidopa—Abdominal pain—Prednisone—ankylosing spondylitis	0.00155	0.00156	CcSEcCtD
Carbidopa—Body temperature increased—Prednisone—ankylosing spondylitis	0.00155	0.00156	CcSEcCtD
Carbidopa—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.00154	0.00155	CcSEcCtD
Carbidopa—Diarrhoea—Betamethasone—ankylosing spondylitis	0.00154	0.00155	CcSEcCtD
Carbidopa—Hypotension—Methotrexate—ankylosing spondylitis	0.00154	0.00154	CcSEcCtD
Carbidopa—Dizziness—Betamethasone—ankylosing spondylitis	0.00149	0.0015	CcSEcCtD
Carbidopa—Dizziness—Dexamethasone—ankylosing spondylitis	0.00149	0.0015	CcSEcCtD
Carbidopa—Insomnia—Methotrexate—ankylosing spondylitis	0.00149	0.00149	CcSEcCtD
Carbidopa—Nausea—Triamcinolone—ankylosing spondylitis	0.00148	0.00148	CcSEcCtD
Carbidopa—Paraesthesia—Methotrexate—ankylosing spondylitis	0.00148	0.00148	CcSEcCtD
Carbidopa—Nausea—Methylprednisolone—ankylosing spondylitis	0.00147	0.00148	CcSEcCtD
Carbidopa—Dyspnoea—Methotrexate—ankylosing spondylitis	0.00146	0.00147	CcSEcCtD
Carbidopa—Somnolence—Methotrexate—ankylosing spondylitis	0.00146	0.00146	CcSEcCtD
Carbidopa—Hypersensitivity—Prednisone—ankylosing spondylitis	0.00145	0.00145	CcSEcCtD
Carbidopa—Dyspepsia—Methotrexate—ankylosing spondylitis	0.00145	0.00145	CcSEcCtD
Carbidopa—Vomiting—Dexamethasone—ankylosing spondylitis	0.00144	0.00144	CcSEcCtD
Carbidopa—Vomiting—Betamethasone—ankylosing spondylitis	0.00144	0.00144	CcSEcCtD
Carbidopa—Decreased appetite—Methotrexate—ankylosing spondylitis	0.00143	0.00143	CcSEcCtD
Carbidopa—Rash—Dexamethasone—ankylosing spondylitis	0.00142	0.00143	CcSEcCtD
Carbidopa—Rash—Betamethasone—ankylosing spondylitis	0.00142	0.00143	CcSEcCtD
Carbidopa—Dermatitis—Dexamethasone—ankylosing spondylitis	0.00142	0.00143	CcSEcCtD
Carbidopa—Dermatitis—Betamethasone—ankylosing spondylitis	0.00142	0.00143	CcSEcCtD
Carbidopa—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.00142	0.00142	CcSEcCtD
Carbidopa—Fatigue—Methotrexate—ankylosing spondylitis	0.00142	0.00142	CcSEcCtD
Carbidopa—Headache—Dexamethasone—ankylosing spondylitis	0.00141	0.00142	CcSEcCtD
Carbidopa—Headache—Betamethasone—ankylosing spondylitis	0.00141	0.00142	CcSEcCtD
Carbidopa—Asthenia—Prednisone—ankylosing spondylitis	0.00141	0.00141	CcSEcCtD
Carbidopa—Pain—Methotrexate—ankylosing spondylitis	0.0014	0.00141	CcSEcCtD
Carbidopa—Pruritus—Prednisone—ankylosing spondylitis	0.00139	0.00139	CcSEcCtD
Carbidopa—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.00135	0.00136	CcSEcCtD
Carbidopa—Diarrhoea—Prednisone—ankylosing spondylitis	0.00134	0.00135	CcSEcCtD
Carbidopa—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.00134	0.00135	CcSEcCtD
Carbidopa—Nausea—Dexamethasone—ankylosing spondylitis	0.00134	0.00134	CcSEcCtD
Carbidopa—Nausea—Betamethasone—ankylosing spondylitis	0.00134	0.00134	CcSEcCtD
Carbidopa—Urticaria—Methotrexate—ankylosing spondylitis	0.00131	0.00131	CcSEcCtD
Carbidopa—Dizziness—Prednisone—ankylosing spondylitis	0.0013	0.0013	CcSEcCtD
Carbidopa—Body temperature increased—Methotrexate—ankylosing spondylitis	0.0013	0.0013	CcSEcCtD
Carbidopa—Abdominal pain—Methotrexate—ankylosing spondylitis	0.0013	0.0013	CcSEcCtD
Carbidopa—Vomiting—Prednisone—ankylosing spondylitis	0.00125	0.00125	CcSEcCtD
Carbidopa—Rash—Prednisone—ankylosing spondylitis	0.00124	0.00124	CcSEcCtD
Carbidopa—Dermatitis—Prednisone—ankylosing spondylitis	0.00124	0.00124	CcSEcCtD
Carbidopa—Headache—Prednisone—ankylosing spondylitis	0.00123	0.00123	CcSEcCtD
Carbidopa—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.00121	0.00121	CcSEcCtD
Carbidopa—Asthenia—Methotrexate—ankylosing spondylitis	0.00118	0.00118	CcSEcCtD
Carbidopa—Nausea—Prednisone—ankylosing spondylitis	0.00117	0.00117	CcSEcCtD
Carbidopa—Pruritus—Methotrexate—ankylosing spondylitis	0.00116	0.00117	CcSEcCtD
Carbidopa—Diarrhoea—Methotrexate—ankylosing spondylitis	0.00112	0.00113	CcSEcCtD
Carbidopa—Dizziness—Methotrexate—ankylosing spondylitis	0.00109	0.00109	CcSEcCtD
Carbidopa—Vomiting—Methotrexate—ankylosing spondylitis	0.00104	0.00105	CcSEcCtD
Carbidopa—Rash—Methotrexate—ankylosing spondylitis	0.00104	0.00104	CcSEcCtD
Carbidopa—Dermatitis—Methotrexate—ankylosing spondylitis	0.00103	0.00104	CcSEcCtD
Carbidopa—Headache—Methotrexate—ankylosing spondylitis	0.00103	0.00103	CcSEcCtD
Carbidopa—Nausea—Methotrexate—ankylosing spondylitis	0.000976	0.000978	CcSEcCtD
